Therapeutics Targeting Pathogenic Mechanisms of Leishmaniasis

A special issue of Biomolecules (ISSN 2218-273X).

Deadline for manuscript submissions: 31 July 2026 | Viewed by 3

Special Issue Editor


E-Mail Website
Guest Editor
Microbiology and Immunology, Center for Cancer Cell Biology, Immunology, and Infection, Chicago Medical School, Rosalind Franklin University of Medicine and Science, 3333 Green Bay Road, North Chicago, IL 60064, USA
Interests: leishmaniasis; host–parasite interactions; pathogenicity; biotechnology; molecular science; vaccine formats; light-activated pesticides
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Leishmaniasis, caused by protozoan parasites of the Leishmania genus, remains a major global health burden, affecting millions in tropical, subtropical, and temperate regions. This is one of the greatly neglected diseases with clinical manifestation in cutaneous, mucocutaneous, and visceral forms. Current treatment options are limited by drug toxicity, high cost, and increasing resistance. A deeper understanding of Leishmania's pathogenic mechanisms—including immune evasion strategies, metabolic adaptations, and intricate vector-host–parasite interactions—is essential for developing next-generation therapeutics.

This Special Issue welcomes the submission of high-quality original research, reviews, and short communications on pioneering therapeutic approaches that target the vector sand fly or unique parasite pathways or host-derived pathogenic immune responses, utilizing in vitro, ex vivo, or in vivo models. Of particular interest will be the exploration of human-specific infection and disease mechanisms by using organoid models based on recent advances in human pluripotent stem cell technology. We encourage submissions on the AI-assisted development of therapeutics, especially pre-clinical research on human subjects or human organoid models, including model development for individualized or precision medicine of infectious diseases. This Special Issue aims to effectively improve the treatment of leishmaniasis by summarizing important contributions from the past and present and exploring future innovative research to link basic science with clinical applications.

Prof. Dr. Kwang Poo Chang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • leishmaniasis
  • host–parasite interactions
  • pathogenicity
  • precision medicine
  • AI-assisted development of therapeutics

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop